HTBX

Heat Biologics (HTBX)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:HTBX
DataOraFonteTitoloSimboloCompagnia
15/05/202322:34Edgar (US Regulatory)Quarterly Report (10-q)AMEX:HTBXHeat Biologics Inc
15/05/202322:28Edgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
31/03/202322:15Edgar (US Regulatory)Annual Report (10-k)AMEX:HTBXHeat Biologics Inc
30/12/202222:06Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:HTBXHeat Biologics Inc
09/12/202223:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:HTBXHeat Biologics Inc
06/06/202222:29Edgar (US Regulatory)Amended Current Report Filing (8-k/a)AMEX:HTBXHeat Biologics Inc
16/05/202222:44GlobeNewswire Inc.NightHawk Biosciences Provides First Quarter 2022 Business UpdateAMEX:HTBXHeat Biologics Inc
10/05/202214:00GlobeNewswire Inc.NightHawk Biosciences to Present at the 4th Annual Treg Directed Therapies Summit on PTX-35AMEX:HTBXHeat Biologics Inc
03/05/202213:00GlobeNewswire Inc.Heat Biologics Completes Name Change to NightHawk Biosciences; Trading to Commence Under “NHWK” Effective at the Market Open TodayAMEX:HTBXHeat Biologics Inc
27/04/202214:00GlobeNewswire Inc.Heat Biologics (NightHawk Biosciences) Announces that its Elusys Therapeutics Subsidiary has Executed a Contract to Deliver ANTHIM® to the Canadian GovernmentAMEX:HTBXHeat Biologics Inc
20/04/202214:00GlobeNewswire Inc.Heat Biologics (“NightHawk Biosciences”) Completes Acquisition of Elusys TherapeuticsAMEX:HTBXHeat Biologics Inc
19/04/202217:00GlobeNewswire Inc.Heat Biologics Announces Planned Name Change to NightHawk Biosciences, Reflecting Company’s Evolution, Therapeutic Pipeline Expansion, Vertical Integration and New Biodefense CapabilitiesAMEX:HTBXHeat Biologics Inc
18/04/202222:00GlobeNewswire Inc.REMINDER: Heat Biologics to Host Planned Investor and Media Livestream Event on Tuesday, April 19th at 10:30 AM ET to Discuss Latest DevelopmentsAMEX:HTBXHeat Biologics Inc
18/04/202214:30GlobeNewswire Inc.Heat Biologics’ Scorpion Subsidiary Announces Planned Development of New Kansas Commercial/Biodefense Biomanufacturing FacilityAMEX:HTBXHeat Biologics Inc
14/04/202218:35GlobeNewswire Inc.Heat Biologics’ Announces Planned Investor and Media Livestream Event to Discuss Latest DevelopmentsAMEX:HTBXHeat Biologics Inc
25/03/202213:00GlobeNewswire Inc.Heat Biologics Unveils Enhanced Allogeneic Cell Manufacturing ProcessAMEX:HTBXHeat Biologics Inc
11/03/202212:33Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-a12b/a)AMEX:HTBXHeat Biologics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:HTBX
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network